Status:
COMPLETED
Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device
Lead Sponsor:
Stéphane Cook, Prof
Conditions:
Blood Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
During the last couple of years, a growing number of wearable devices evolved to provide accurate, cheap and non-invasive monitoring of vitals parameters.This connected care technology could be helpfu...
Detailed Description
Several cuff-less blood pressure monitoring devices have emerged in patient care using photoplethysmography. PPG utilizes an infrared or visible light to measure peripheral volumetric variations of bl...
Eligibility Criteria
Inclusion
- Participants fulfilling the following inclusion criteria are eligible for the study:
- Age ≥ 18 years
- Patients referred for coronarography
- Patient in the intensive care unit requiring invasive blood pressure monitoring and with an arterial catheter in place at the time of inclusion to the study
- The presence of any of the following exclusion criteria will lead to exclusion of the participant:
- Unable or unwilling to provide written informed consent
- Coronarography in patients with myocardial infarction
- Patient with suspected or certified COVID-infection
- Patients with atrial fibrillation
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04379986
Start Date
May 1 2020
End Date
May 31 2020
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University and hospital Fribourg
Fribourg, Switzerland, 1700